MedVenture
The computed 12-month bankruptcy probability of MedVenture is 0.1% (very low). The 2024 annual accounts show equity of €1.12M and a net result of €80k. Equity is growing by ~12.9% per year across the filed fiscal years. Its solvency ranks better than 95% of 12451 sector peers (fiscal year 2024). The company has been active since 2007 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €1.12M |
| Net result | €80k |
| Better than sector | 95% |
| Active | 19 yrs |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 98.2% | 60.6% | |
| Net result | €80k | €31k | |
| Equity | €1.12M | €63k | |
| Gross operating margin | €105k | €52k | |
| Total assets | €1.14M | €124k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €104k |
| Net profit | €80k |
| Cash flow | €87k |
| Staff costs | - |
| Income taxes | €31k |
| Dividends | €833 |
| Total assets | €1.14M |
| Equity | €1.12M |
| Debt | €20k |
| of which ≤ 1y | €16k |
| of which > 1y | - |
| Working capital | €1.11M |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 69.98 |
| Quick ratio | 69.98 |
| Working capital ratio | 97.1% |
| Solvency | 98.2% |
| Debt / equity | 0.02 |
| Long-term debt ratio | - |
| Interest coverage | 131.93 |
| Gross margin | - |
| Net margin | - |
| ROA | 7.1% |
| ROE | 7.2% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €1.14M |
| Fixed assets | 21/28 | €17k |
| Tangible fixed assets | 22/27 | €17k |
| Financial fixed assets | 28 | €45 |
| Current assets | 29/58 | €1.12M |
| Amounts receivable within one year | 40/41 | €40k |
| Investments | 50/53 | €411k |
| Cash & bank | 54/58 | €656k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.14M |
| Equity | 10/15 | €1.12M |
| Contributions / capital | 10/11 | €100 |
| Reserves | 13 | €1.12M |
| Accumulated profits (losses) | 14 | €0 |
| Amounts payable | 17/49 | €20k |
| Amounts payable within one year | 42/48 | €16k |
| Trade debts payable within one year | 44 | €8k |
| Income statement | ||
| Gross operating margin | 9900 | €105k |
| Operating result | 9901 | €97k |
| Financial income | 75 | €15k |
| Financial charges | 65 | €787 |
| Result before taxes | 9903 | €111k |
| Income taxes | 67/77 | €31k |
| Net result for the period | 9904 | €80k |
| Result to be appropriated | 9905 | €80k |
| NACE primary | Head offices & management consulting(70200) |
| Legal form | Private limited company(610) |
| Incorporation | 26-03-2007 |
| Status | Active |
| Postal code | 2000 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11811L3591/00C002 | Flanders | 262 m² | 1 · 166 m² | 25.2 m · 6 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
05-01-2023 Change in the board of directors
Technical details
{
"events": [
{
"kind": "substantive_delegation",
"role": null,
"person": null,
"reason": null,
"subkind": null,
"via_org": {
"kbo": "0567.793.656",
"name": "VP Accountants \u0026 Belastingconsulenten BV",
"address": "Mechelsebaan 18, BE-3140 Keerbergen",
"country": "BE",
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Bovendien werd bijzondere volmacht verleend, met recht van indeplaatsstelling, teneinde alle formaliteiten te vervullen bij de griffies en/of ondernemingsloketten, en bij de administratie van de BTW, inzake de inschrijving van de vennootschap, de wijzigingen daarvan en de schrapping, aan : VP Accoun",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Wesley CIELEN",
"firm_city": null,
"firm_name": "De Cleene \u0026 De Deken, geassocieerde notarissen",
"office_city": "Antwerpen",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2023-01-05",
"filing_date": "2023-01-03",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2022-12-19",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0888.413.793",
"name_full": "MedVenture",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Wesley Cielen",
"org_rep_person_name": null,
"person_role_at_subject": "notaris-plaatsvervanger"
},
"co_filed_documents": [
"uitgifte akte",
"statuten"
],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | MedVenture |